Related Experiment Videos
Follow-up study of pseudoephedrine users
Annals of Allergy
|November 1, 1986
Summary
Pseudoephedrine use in over 100,000 individuals showed no drug-related hospitalizations. Adverse event rates for myocardial infarction and other conditions were similar to the general population.
Area of Science:
- Pharmacovigilance
- Public Health
- Clinical Pharmacology
Background:
- Pseudoephedrine is a common decongestant.
- Concerns exist regarding potential cardiovascular and neurological adverse events.
Purpose of the Study:
- To assess the safety of pseudoephedrine by evaluating hospitalization rates for specific adverse events.
- To determine if pseudoephedrine use is associated with increased risk of serious health outcomes.
Main Methods:
- Follow-up study of over 100,000 individuals under 65 years old.
- Analysis of 243,286 pseudoephedrine prescriptions.
- Comparison of hospitalization rates for pseudoephedrine users versus the general population.
Main Results:
- No hospitalizations were directly attributed to pseudoephedrine use.
- No increase in admissions for cerebral hemorrhage, thrombotic stroke, or hypertensive crisis within 15 days of prescription.
- A small number of hospitalizations for myocardial infarction, seizures, and neuropsychiatric disorders occurred at rates comparable to the general population.
Conclusions:
- Pseudoephedrine appears to have a favorable safety profile in individuals under 65.
- The study did not find evidence of significant safety concerns associated with pseudoephedrine use in this population.